Exclusive Live Webinar | February 26, 2025 | 12 PM EST / 11 AM CST
Prepare your organization for the evolving regulatory landscape with expert insights from former FDA leaders and industry compliance specialists.
FDA inspections are becoming more rigorous, and staying ahead of compliance expectations is crucial for pharmaceutical, biopharmaceutical, and medical device companies. This 90-minute online webinar will provide you with the latest trends, best practices, and actionable strategies to strengthen your FDA inspection readiness in 2025 and beyond.
Why Attend?
Regulatory compliance is more complex than ever. With increased scrutiny and evolving FDA requirements, organizations must be proactive in their inspection preparation. This exclusive session, led by former FDA officials and top industry experts, will deliver insider knowledge and proven strategies to help you navigate regulatory challenges with confidence.
What You’ll Gain:
✔️ Insightful Analysis – Learn the latest FDA inspection trends and regulatory priorities for 2025
✔️ Proven Strategies – Discover best practices for achieving and maintaining compliance
✔️ Expert Guidance – Hear from former FDA regulators and industry veterans with decades of experience
✔️ Real-World Case Studies – Gain practical knowledge from real compliance scenarios
✔️ Actionable Takeaways – Implement step-by-step strategies for seamless FDA interactions
Who Should Attend?
This webinar is designed for professionals in:
🔹 Pharmaceutical & Biopharmaceutical Companies
🔹 Medical Device Manufacturers
🔹 Clinical Research Organizations (CROs)
🔹 Institutional Review Boards (IRBs)
🔹 Regulatory Affairs & Quality Assurance Teams
🔹 Compliance & Risk Management Leaders
Meet the Experts
Gain invaluable insights from renowned regulatory professionals and former FDA authorities:
🔹 Teresa Gorecki – Practice Director, Compliance Architects®
- Expert in quality assurance, regulatory compliance, and FDA approval processes
🔹 Diluks De Silva – Vice President, Compliance Architects
- Specialist in Cell and Gene Therapy (CGT) and radiopharmaceutical regulatory strategies
🔹 Ricki Chase – Ex-FDA and Principal Consultant
- Former FDA Director of Investigations with extensive experience in GxP compliance and global audits
🔹 Gerard Appert – Chief Operating Officer, Compliance Architects
- An industry leader in compliance strategy and regulatory operations for life sciences companies
Reserve Your Spot Today!
Don’t miss this opportunity to enhance your compliance strategy and prepare your organization for FDA success in 2025. Secure your place in this high-value session now!
🔗 Webinar registration link coming soon – stay updated! For more information, visit ComplianceArchitects.com.
